Post
of 21,322
$VTVT News Article - vTv Therapeutics to Host Investor Call and Announce Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 - Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes https://marketwirenews.com/news-releases/vtv-...40758.html
My Twitter: WhyteStocks